Elevance Health Inc. (ELV) Tops Q2 EPS by 11c

Elevance Health Inc. (NYSE: ELV) reported Q2 EPS of $10.12, $0.11 better than the analyst estimate of $10.01. Revenue for the quarter came in at $43.22 billion versus the consensus estimate of $43.05 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
• BofA Securities Upgrades Etsy (ETSY) to Buy, 'Still Room to Run'
• Lucid Capital Markets Starts Eloxx Pharma (ELOX) at Buy